Quanex building products corporation (NX)
CashFlow / Yearly
Oct'19Oct'18Oct'17Oct'16Oct'15Oct'14Oct'13Oct'12Oct'11Oct'10Oct'09
Operating activities:
Net income (loss)

-46,730

26,553

18,683

-1,859

16,093

29,234

-11,703

-16,534

9,066

23,098

-137,091

Adjustments to reconcile net income (loss) to cash used for operating activities:
Loss (gain) on disposition of capital assets

-732

142

-1,528

20

-495

-586

449

-989

374

677

-

Loss (income) from discontinued operations

-

-

-

-

-

-

-

-

-

-1,103

-1,012

Depreciation and amortization

49,586

51,822

57,495

53,146

35,220

36,910

60,504

37,596

33,932

28,283

32,523

Stock-based compensation

2,045

1,874

5,189

6,089

4,266

3,925

4,910

4,403

4,703

4,456

3,429

Deferred income tax

3,260

-5,556

-112

-8,469

5,204

14,246

-8,288

-9,843

3,361

12,294

-43,609

Excess tax benefit from share-based compensation

-

-

-

-

60

654

-236

-496

-226

-

-

Noncash charge for deferred loan costs and debt discount

0

1,064

0

16,022

0

0

-

-

-

-

-

Gain on bargain purchase

-

-

-

-

-

-

-

-

-

1,272

-

Restructuring charges

-

-

-

-

-

-

0

-122

721

0

-

Other, net

-2,176

-135

-1,741

-339

19

-2,105

781

2,638

949

-

-

Goodwill impairment charges

74,600

0

-

-

-

-

-

-

-

-

-

Asset impairment charges

74,600

0

0

12,602

0

1,007

1,465

912

1,799

0

182,562

Gain on sale of discontinued operations

-

-

-

-

-

39,122

-

-

-

-

-

Gain on involuntary conversion

-

-

-

-

1,263

2,408

-

-

-

-

-

Changes in assets and liabilities:
Decrease in accounts receivable

-574

5,550

-5,378

-796

-2,668

-484

-9,204

-4,250

13,761

6,365

-18,636

Increase in inventory

-3,797

-17,230

3,240

-5,346

-9,805

25,650

12,791

-10,288

-530

-3,142

-16,503

Decrease in other current assets

2,014

-217

-186

-2,503

1,304

1,098

1,622

-50

741

510

122

Decrease in accounts payable

8,124

8,325

-4,893

-2,273

-2,862

12,842

-5,903

14,920

-13,349

4,572

-12,306

Decrease in accrued liabilities

-6,760

6,892

-7,521

2,033

-576

-6,871

-7,473

8,539

-7,125

9,509

-3,119

(Decrease) increase in income taxes payable

3,416

676

4,670

-365

369

866

1,708

-547

-493

9,599

-922

Increase in deferred pension and postretirement benefits

2,531

2,038

-271

588

-372

-347

-164

-693

2,768

-1,846

-407

Decrease in other long-term liabilities

513

-523

1,382

956

-283

-2,172

1,574

678

778

-

-

Other, net

-522

444

437

93

294

3,105

688

604

1,714

-4,176

-4,213

Cash provided by operating activities

-

-

-

87,341

67,087

20,778

-

-

-

89,562

61,302

Cash provided by (used for) operating activities from discontinued operations

-

-

-

-

-

-

-

-

-

-430

-811

Cash used for operating activities

96,372

104,611

79,778

-

-

-

43,521

26,478

52,944

89,132

60,491

Investing activities:
Net proceeds from sale of discontinued operations

-

-

-

-

-

107,431

-

-

-

-

-

Acquisitions, net of cash acquired

-

-

-

245,904

131,689

5,161

22,096

0

110,845

1,590

-

Payments to Acquire Property, Plant, and Equipment

24,883

26,484

34,564

37,243

29,982

33,779

37,931

42,871

25,312

14,720

15,696

Proceeds from disposition of capital assets

1,324

432

1,937

1,044

264

832

340

44

107

-

-

Proceeds from property insurance claim

-

-

-

-

1,263

4,801

0

1,123

0

392

1,400

Other, net

-

-

-

-

-

-

-

-

-

-43

57

Proceeds from executive life Insurance

-

-

-

-

-

-

0

0

683

0

-

Cash used for investing activities

-

-

-

-282,103

-160,144

74,124

-

-

-

-15,875

-14,353

Cash provided by (used for) investing activities from discontinued operations

-

-

-

-

-

-

-

-

-

90

-457

Cash used for investing activities

-23,559

-26,052

-32,627

-

-

-

-59,687

-41,704

-135,367

-15,785

-14,810

Financing activities:
Borrowings under credit facility

83,500

268,500

53,500

634,800

117,000

0

23,500

0

0

-

-

Repayments of Lines of Credit

136,000

296,250

98,875

422,875

67,000

0

23,500

0

0

-

-

Issuance of common stock from stock option exercises, including related tax benefits

-

-

-

-

-

-

-

-

-

502

-

Debt issuance costs

0

1,001

0

11,435

496

0

1,200

0

0

-

-

Repayments of other long-term debt

1,526

1,798

2,722

2,185

1,020

175

557

264

340

323

363

Common stock dividends paid

10,644

7,020

5,516

5,470

5,515

5,992

5,931

5,891

5,979

5,275

4,519

Issuance of common stock

3,287

4,746

7,953

3,400

5,109

3,249

2,583

3,015

867

-

-

Payment of acquisition earn-out contingency

0

0

8,497

-

-

-

-

-

-

-

-

Cash paid for payroll tax for shares forfeited upon vesting

330

960

976

787

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation

-

-

-

-

60

654

236

496

226

-

-

Purchase of treasury stock

9,551

32,034

0

0

52,719

22,281

0

1,284

10,080

4,274

-

Funding from Separation

-

-

-

-

-

-

-

-

-

-

15,401

Other, net

-

-

-

-

-

86

-

-

392

-665

-876

Cash provided by (used for) financing activities

-

-

-

195,448

-4,581

-24,459

-

-

-

-10,035

9,643

Cash provided by (used for) financing activities from discontinued operations

-

-

-

-

-

-

-

-

-

665

865

Cash provided by financing activities

-71,264

-65,817

-55,133

-

-

-

-4,869

-3,928

-14,914

-9,370

10,508

Effect of exchange rate changes on cash and cash equivalents

316

-1,194

-89

1,715

379

207

-484

790

-222

27

36

Less: (Increase) decrease in cash and equivalents from discontinued operations

-

-

-

-

-

-

-

-

-

-325

403

Decrease in cash and cash equivalents

1,865

11,548

-8,071

2,401

-97,259

70,650

-21,519

-18,364

-97,559

63,679

56,628